Ironwood Pharmaceuticals Inc (IRWD)
Inventory turnover
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Cost of revenue | US$ in thousands | 175,757 | 115,994 | 112,206 | 158,521 | 199,945 |
Inventory | US$ in thousands | 0 | 1,250 | 1,250 | 0 | 648 |
Inventory turnover | — | 92.80 | 89.76 | — | 308.56 |
December 31, 2023 calculation
Inventory turnover = Cost of revenue ÷ Inventory
= $175,757K ÷ $0K
= —
The inventory turnover for Ironwood Pharmaceuticals Inc was not provided for the years 2020, 2021, 2022, and 2023. However, in 2019, the company had an inventory turnover of 36.84 times. This indicates that in 2019, Ironwood Pharmaceuticals efficiently managed its inventory by selling and replacing its inventory approximately 36.84 times during that year. Without data for the subsequent years, it is difficult to assess the trend in inventory turnover and its impact on the company's operations and financial performance.
Peer comparison
Dec 31, 2023
Company name
Symbol
Inventory turnover
Ironwood Pharmaceuticals Inc
IRWD
—
Abbott Laboratories
ABT
4.78
AbbVie Inc
ABBV
11.08
Alkermes Plc
ALKS
5.28
Amphastar P
AMPH
2.77
ANI Pharmaceuticals Inc
ANIP
3.62
Arcus Biosciences Inc
RCUS
—
Biomarin Pharmaceutical Inc
BMRN
0.47
Bristol-Myers Squibb Company
BMY
10.53
Catalent Inc
CTLT
5.97
Catalyst Pharmaceuticals Inc
CPRX
13.95